[Federal Register: October 17, 2008 (Volume 73, Number 202)]
[Notices]
[Page 61909-61911]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr17oc08-136]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on July 15, 2008, Cerilliant
Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402,
made application by renewal to the Drug Enforcement Administration
(DEA) as a bulk manufacturer of the basic classes of
[[Page 61910]]
controlled substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)............................ I
Methcathinone (1237)........................ I
N-Ethylamphetamine (1475)................... I
N,N-Dimethylamphetamine (1480).............. I
Aminorex (1585)............................. I
4-Methylaminorex (cis isomer) (1590)........ I
Gamma-Hydroxybutyric acid (2010)............ I
Methaqualone (2565)......................... I
Alpha-ethyltryptamine (7249)................ I
Lysergic acid diethylamide (7315)........... I
Marihuana (7360)............................ I
Tetrahydrocannabinols (7370)................ I
Mescaline (7381)............................ I
3,4,5-Trimethoxyamphetamine (7390).......... I
4-Bromo-2,5-dimethoxyamphetamine (7391)..... I
4-Bromo-2,5-dimethoxyphenethylamine (7392).. I
4-Methyl-2,5-dimethoxyamphetamine (7395).... I
2,5-Dimethoxyamphetamine (7396)............. I
2,5-Dimethoxy-4-ethylamphetamine (7399)..... I
3,4-Methylenedioxyamphetamine (7400)........ I
5-Methoxy-3,4-methylenedioxyamphetamine I
(7401).
N-Hydroxy-3,4-methylendioxyamphetamine I
(7402).
3,4-Methylendioxy-N-ethylamphetamine (7404). I
3,4-Methylenedioxymethamphetamine (7405).... I
4-Methoxyamphetamine (7411)................. I
Alpha-methyltryptamine (7432)............... I
Bufotenine (7433)........................... I
Diethyltryptamine (7434).................... I
Dimethyltryptamine (7435)................... I
Psilocybin (7437)........................... I
Psilocyn (7438)............................. I
N-Benzylpiperazine (7493)................... I
Acetyldihydrocodeine (9051)................. I
Benzylmorphine (9052)....................... I
Codeine-N-oxide (9053)...................... I
Dihydromorphine (9145)...................... I
Heroin (9200)............................... I
Hydromorphinol (9301)....................... I
Methyldihydromorphine (9304)................ I
Morphine-N-oxide (9307)..................... I
Normorphine (9313).......................... I
Pholcodine (9314)........................... I
Acetylmethadol (9601)....................... I
Allylprodine (9602)......................... I
Alphacetylmethadol except levo- I
alphacetylmethadol (9603).
Alphameprodine (9604)....................... I
Alphamethadol (9605)........................ I
Betacetylmethadol (9607).................... I
Betameprodine (9608)........................ I
Betamethadol (9609)......................... I
Betaprodine (9611).......................... I
Hydroxypethidine (9627)..................... I
Noracymethadol (9633)....................... I
Norlevorphanol (9634)....................... I
Normethadone (9635)......................... I
Trimeperidine (9646)........................ I
Phenomorphan (9647)......................... I
Para-Fluorofentanyl (9812).................. I
3-Methylfentanyl (9813)..................... I
Alpha-Methylfentanyl (9814)................. I
Acetyl-alpha-methylfentanyl (9815).......... I
Beta-hydroxyfentanyl (9830)................. I
Beta-hydroxy-3-methylfentanyl (9831)........ I
Alpha-Methylthiofentanyl (9832)............. I
3-Methylthiofentanyl (9833)................. I
Thiofentanyl (9835)......................... I
Amphetamine (1100).......................... II
Methamphetamine (1105)...................... II
Phenmetrazine (1631)........................ II
Methylphenidate (1724)...................... II
Amobarbital (2125).......................... II
[[Page 61911]]
Pentobarbital (2270)........................ II
Secobarbital (2315)......................... II
Glutethimide (2550)......................... II
Nabilone (7379)............................. II
1-Phenylcyclohexylamine (7460).............. II
Phencyclidine (7471)........................ II
1-Piperidinocyclohexanecarbonitrile (8603).. II
Alphaprodine (9010)......................... II
Cocaine (9041).............................. II
Codeine (9050).............................. II
Dihydrocodeine (9120)....................... II
Oxycodone (9143)............................ II
Hydromorphone (9150)........................ II
Diphenoxylate (9170)........................ II
Benzoylecgonine (9180)...................... II
Ethylmorphine (9190)........................ II
Hydrocodone (9193).......................... II
Levomethorphan (9210)....................... II
Levorphanol (9220).......................... II
Isomethadone (9226)......................... II
Meperidine (9230)........................... II
Meperidine intermediate-A (9232)............ II
Meperidine intermediate-B (9233)............ II
Meperidine intermediate-C (9234)............ II
Methadone (9250)............................ II
Methadone intermediate (9254)............... II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................. II
Thebaine (9333)............................. II
Levo-alphacetylmethadol (9648).............. II
Oxymorphone (9652).......................... II
Noroxymorphone (9668)....................... II
Racemethorphan (9732)....................... II
Alfentanil (9737)........................... II
Sufentanil (9740)........................... II
Fentanyl (9801)............................. II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances to make reference standards which will be
distributed to their customers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than December 16, 2008.
Dated: October 9, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-24771 Filed 10-16-08; 8:45 am]
BILLING CODE 4410-09-P